An Extension Study to Evaluate the Long-Term Safety of FCFD4514S in Patients With Geographic Atrophy

Clinical Trial ID NCT01602120

PubWeight™ 4.46‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01602120

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunology of age-related macular degeneration. Nat Rev Immunol 2013 2.14
2 Applying complement therapeutics to rare diseases. Clin Immunol 2015 0.87
3 Targeting the complement system for the management of retinal inflammatory and degenerative diseases. Eur J Pharmacol 2016 0.78
4 Targeting inflammation in emerging therapies for genetic retinal disease. Int J Inflam 2013 0.77
Next 100